Jane H Hollingsworth

CIK 1297141 · Chief Executive Officer · last filed 2026-06-10

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$2.32M

Companies

3

Total Filings

16

Lifetime Open-Market Net

$71.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
CRVO	Director	943	$2.45	$2.3K	$0	5	2026-06-10
CervoMed Inc. (DFFN) Delisted	Director	1,231	$6.60	$8.1K	$20.0K	8	2023-06-02
PATH	Chief Executive Officer	219,838	$10.55	$2.32M	$51.3K	3	2012-03-27

Recent Filings · Page 2 of 2

16 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2021-07-06	CervoMed Inc. (DFFN) Delisted	Grant (A)	—	$0	EDGAR
2021-05-17	CervoMed Inc. (DFFN) Delisted	Buy (P)	+32,786	$20.0K	EDGAR
2020-10-01	CervoMed Inc. (DFFN) Delisted	Grant (A)	—	$0	EDGAR
2012-03-27	PATH	Grant (A)	—	$0	EDGAR
2011-09-12	PATH	Buy (P)	+20,000	$51.3K	EDGAR
2010-08-12	PATH	Conv (C)	+37,640	$51.4K	EDGAR

Showing 11–16 of 16

Prev Page 2 of 2

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.